Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.

Guo F, Hirth JM, Berenson AB.

Prev Med. 2015 Dec;81:427-32. doi: 10.1016/j.ypmed.2015.10.005. Epub 2015 Oct 21.

PMID:
26500084
2.

Estrogen and ERalpha: culprits in cervical cancer?

Chung SH, Franceschi S, Lambert PF.

Trends Endocrinol Metab. 2010 Aug;21(8):504-11. doi: 10.1016/j.tem.2010.03.005. Epub 2010 Apr 22. Review.

3.

Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older women.

Sawaya GF, Iwaoka-Scott AY, Kim S, Wong ST, Huang AJ, Washington AE, Pérez-Stable EJ.

Am J Obstet Gynecol. 2009 Jan;200(1):40.e1-7. doi: 10.1016/j.ajog.2008.07.015. Epub 2008 Oct 30.

4.

The effects of tibolone in older postmenopausal women.

Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, Mol-Arts M, Kloosterboer L, Mosca L, Christiansen C, Bilezikian J, Kerzberg EM, Johnson S, Zanchetta J, Grobbee DE, Seifert W, Eastell R; LIFT Trial Investigators.

N Engl J Med. 2008 Aug 14;359(7):697-708. doi: 10.1056/NEJMoa0800743.

5.

The frequency of Pap smear screening in the United States.

Sirovich BE, Welch HG.

J Gen Intern Med. 2004 Mar;19(3):243-50.

6.

How can we develop a cost-effective quality cervical screening programme?

Wilson S, Lester H.

Br J Gen Pract. 2002 Jun;52(479):485-90. Review.

Items per page

Supplemental Content

Write to the Help Desk